Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 17 results:
Author Title Type [ Year] Filters: Author is Petridis, Dimitris [Clear All Filters]
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination..
Expert Rev Respir Med.
(2020). Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA..
J Cancer. 11(21), 6454-6459.
(2020). Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?.
J Cancer. 11(6), 1606-1613.
(2020). EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE..
J Cancer. 10(20), 4739-4746.
(2019). EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE ®.
Journal of Cancer. 10(20), 4739 - 4746.
(2019). Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department..
J Thorac Dis. 7(Suppl 1), S12-9.
(2015). Reduction of exercise capacity in sarcoidosis in relation to disease severity..
Patient Prefer Adherence. 9, 1179-88.
(2015). Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach..
Ther Clin Risk Manag. 10, 77-86.
(2014). Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil..
J Thorac Dis. 6(10), 1411-9.
(2014). Experimentation with inhaled bronchodilators and corticosteroids..
Int J Pharm. 461(1-2), 411-8.
(2014). Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment..
Drug Des Devel Ther. 8, 1753-63.
(2014). A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience..
J Cancer. 5(6), 433-45.
(2014). Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol..
Drug Des Devel Ther. 8, 1065-72.
(2014). Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup..
Int J Pharm. 453(2), 480-7.
(2013). Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems..
Int J Pharm. 458(1), 39-47.
(2013).
(2013).
(2013).